Planned sale of 13,109 Company (NASDAQ: CGON) shares disclosed in filing
Rhea-AI Filing Summary
CGON filed a notice of proposed sale of restricted or control securities. The filing covers the planned sale of 13,109 common shares, with an aggregate market value of $549,660.37, through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 01/09/2026. The issuer had 80,666,179 common shares outstanding. The shares to be sold were acquired on 01/09/2026 by exercising stock options granted by the issuer, paid for in cash on the same date.
Positive
- None.
Negative
- None.
FAQ
What does the CGON Form 144 filing disclose?
The Form 144 discloses a planned sale of 13,109 shares of CGON common stock, acquired via stock option exercise and proposed to be sold on NASDAQ through a broker.
How many CGON shares are planned to be sold and what is their value?
The notice covers 13,109 common shares with an aggregate market value of $549,660.37.
How were the CGON shares being sold under Form 144 acquired?
The shares were acquired on 01/09/2026 through an exercise of stock options from the issuer, with the purchase price paid in cash on the same date.
Which broker is handling the planned CGON share sale?
The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, based at 1 New York Plaza, New York, NY 10004.
On which exchange are the CGON shares intended to be sold?
The filing indicates that the common shares are intended to be sold on the NASDAQ stock market.
How many CGON shares were outstanding at the time referenced in the filing?
The Form 144 states that there were 80,666,179 common shares outstanding for the issuer.
What is the approximate date of the planned CGON share sale in this Form 144?
The approximate date of sale listed for the 13,109 common shares is 01/09/2026.